Opdivo plus chemo improves event-free survival in NSCLC patients
Detailed results from the CheckMate-816 trial will be shared at an upcoming medical conference
Read More
Author: Lucy Parsons
AZ announces US fast track designation for IL-5 inhibitor Fasenra
Designation granted for the treatment of eosinophilic gastritis with or without eosinophilic gastroenteritis
Read More
UK gov’t warns of Christmas COVID restrictions, push for booster vaccines
Around 60% of those eligible have received their booster vaccinations in the UK
Read More
Pfizer’s COVID-19 pill cuts hospitalisation/death risk by 89%
The trial evaluated the investigational medicine in non-hospitalised adult patients with COVID-19 who are at high-risk of progressing to severe illness
Read More
Novartis’ iptacopan hits endpoints in mid-stage study
Investigational treatment is being evaluated in patients with C3 glomerulopathy
Read More- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
